Novo Nordisk
-
Novo Nordisk Pharmatech and Novozymes collaborate to manufacture specialty enzymes
DENMARK – Novozymes and Novo Nordisk Pharmatech have announced a collaboration agreement that brings together the companies’ shared competencies and interests in the development of…
-
Novo Nordisk’s high-dose obesity drug, Wegovy approved in Canada
DENMARK – Novo Nordisk has announced that Health Canada has approved Wegovy (semaglutide injection), the first and only prescription weight-loss medication with a once-weekly dosing…
-
Denmark’s Novo Nordisk reaches US$3.3 billion deal to acquire Dicerna Pharma
DENMARK – Novo Nordisk, a Danish pharmaceutical company, has agreed to buy Dicerna Pharmaceuticals for US$3.3 billion in cash, the company has announced. Dicerna Pharmaceuticals…
-
Biocorp and Novo Nordisk ink partnership deal to enhance diabetes care
DENMARK – Novo Nordisk, a world leader in diabetes care, has partnered with French-based device maker Biocorp to smarten up its line of disposable FlexTouch…
-
US Food and Drug Administration approves Novo Nordisk’s weight management drug Wegovy
DENMARK – Novo Nordisk, a Danish drug company that focuses on lifestyle related diseases, has finally received the US Food & Drug Administration (USFDA) approval…
-
Diabetes tech market continues to witness an upward trend as more companies are coming up with new innovations
US – Despite the volatility of last year’s economy due to the corona virus pandemic, diabetes technology companies experienced tremendous success. Analysts have been bullish…
-
Lilly’s tirzepatide tops list ahead of ozempic as treatment candidate for type 2 diabetes
US – In the just concluded phase 3 trials, the American pharmaceutical company, Eli Lilly have provided results that showed its investigational Gastric inhibitory polypeptide…